Nonalcoholic Fatty Liver Disease in Humans Is Associated with Increased Plasma Endotoxin and Plasminogen Activator Inhibitor 1 Concentrations and with Fructose Intake
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Du, X.-L., Edelstein, D., Rossetti, L., Fantus, I. G., Goldberg, H., Ziyadeh, F., Wu, J., & Brownlee, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12222 · Cited by 1,152
Brun, P., Castagliuolo, I., Leo, V. D., Buda, A., Pinzani, M., Palù, G., & Martines, D. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2006 · Cited by 864
Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., & Cummins, A. G. (2001) · Gut · doi:10.1136/gut.48.2.206 · Cited by 840
Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Blendis, L., Halpern, Z., & Oren, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.020 · Cited by 551
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin
Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., McClain, C. J., & Bischoff, S. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.035 · Cited by 522
Self-citationPrevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1
Ma, L.-J., Mao, S.-L., Taylor, K. L., Kanjanabuch, T., Guan, Y., Zhang, Y., Brown, N. J., Swift, L. L., McGuinness, O. P., Wasserman, D. H., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.2.336 · Cited by 397
Faeh, D., Minehira, K., Schwarz, J.-M., Periasamy, R., Park, S., & Tappy, L. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1907 · Cited by 386
Dietary habits and nutrient intake in non-alcoholic steatohepatitis
Toshimitsu, K., Matsuura, B., Ohkubo, I., Niiya, T., Furukawa, S., Hiasa, Y., Kawamura, M., Ebihara, K., & Onji, M. (2007) · Nutrition · doi:10.1016/j.nut.2006.09.004 · Cited by 264
Meckling, K. A., O’Sullivan, C., & Saari, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031606 · Cited by 233
Ackerman, Z., Oron-Herman, M., Grozovski, M., Rosenthal, T., Pappo, O., Link, G., & Sela, B.-A. (2005) · Hypertension · doi:10.1161/01.hyp.0000164570.20420.67 · Cited by 223
Dietary Composition and Nonalcoholic Fatty Liver Disease
Solga, S., Alkhuraishe, A. R., Clark, J. M., Torbenson, M., Greenwald, A., Diehl, A. M., & Magnuson, T. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000043367.69470.b7 · Cited by 213
Nair, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02265-1 · Cited by 212
Bergheim, I., Guo, L., Davis, M. A., Lambert, J. C., Beier, J. I., Duveau, I., Luyendyk, J. P., Roth, R. A., & Arteel, G. E. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.020 · Cited by 205
Self-citationPlasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue Accumulation
Alessi, M.-C., Bastelica, D., Mavri, A., Morange, P., Berthet, B., Grino, M., & Juhan-Vague, I. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000077401.36885.bb · Cited by 178
Critical Role of Plasminogen Activator Inhibitor-1 in Cholestatic Liver Injury and Fibrosis
Bergheim, I., Guo, L., Davis, M. A., Duveau, I., & Arteel, G. E. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095042 · Cited by 155
Self-citationZhang, Q., Wu, Y., Ann, D. K., Messadi, D. V., Tuan, T., Kelly, A., Bertolami, C. N., & Le, A. D. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12564.x · Cited by 96
Lewis, G. F., Murdoch, S. J., Uffelman, K. D., Naples, M., Szeto, L., Albers, A., Adeli, K., & Brunzell, J. D. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2893 · Cited by 77
NOSOVA, T., JOKELAINEN, K., KAIHOVAARA, P., JOUSIMIES-SOMER, H., SIITONEN, A., HEINE, R., & SALASPURO, M. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008191 · Cited by 74
Fearns, C., & Loskutoff, D. J. (1997) · Europe PMC (PubMed Central) · Cited by 67
Increased Orocecal Transit Time in Patients with Nonalcoholic Fatty Liver Disease
Soza, A., Riquelme, A. J., Gonzalez, R. G., Alvarez, M. G., Pérez‐Ayuso, R. M., Glasinovic, J. C., & Arrese, M. A. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2720-8 · Cited by 52
Jensen, L., Sloth, B., Krog-Mikkelsen, I., Flint, A., Raben, A., Tholstrup, T., Brünner, N., & Astrup, A. V. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.97 · Cited by 42
Radha, K. S., Sugiki, M., KUMAR, M. H., Omura, S., & Maruyama, M. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01272.x · Cited by 11
Cited by
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
“Assessment of fatty liver disease Translocation of bacterial or bacterial products such as LPS from the intestine to the liver has been proposed as trigger for liver inflammation and fatty liver disease [151].”
BackgroundSelf-citationIncreased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434
“n 17 18 14 21 Sex (M) 3/14 2/16 NS 3/11 2/19 NS Age 44 (34-53) 41 (32-54) NS 46(32-54) 40 (32-53 NS BMI 24.”
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Tappy, L., & Lê, K.-A. (2010) · Physiological Reviews · doi:10.1152/physrev.00019.2009 · Cited by 1,256
The role of the gut microbiota in NAFLD
Leung, C., Rivera, L., Furness, J. B., & Angus, P. W. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.85 · Cited by 1,020
Metadata
- Authors
- Thuy, S., Ladurner, R., Volynets, V., Wagner, S., Strahl, S., Königsrainer, A., Maier, K.-P., Bischoff, S. C., & Bergheim, I.
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 138
- Issue
- 8
- Pages
- 1452-1455
- ISSN
- 0022-3166 (ISSN-L)
- OpenAlex
- W2164567049
- Cited by
- 412
- References
- 24
- FWCI
- 13.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.